Mycobacterium tuberculosis H37Rv LpqG Protein Peptides Can Inhibit Mycobacterial Entry through Specific Interactions

Mycobacterium tuberculosis H37Rv LpqG Protein Peptides Can Inhibit Mycobacterial Entry through Specific Interactions

Mycobacterium tuberculosis is the causative agent of tuberculosis, a disease causing major mortality worldwide. As part of a systematic methodology for studying M. tuberculosis surface proteins which might be involved in host-pathogen interactions, our group found that LpqG surface protein (Rv3623)...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Christian David Sánchez-Barinas, Marisol Ocampo, Magnolia Vanegas, Jeimmy Johana Castañeda-Ramirez, Manuel Alfonso Patarroyo, Manuel Elkin Patarroyo
Natura:	Articolo
Lingua:	English
Pubblicazione:	MDPI AG 2018-02-01
Serie:	Molecules
Soggetti:	LpqG lipoprotein Mycobacterium tuberculosis vaccine synthetic peptide Rv3623 mycobacterial entry inhibition
Accesso online:	http://www.mdpi.com/1420-3049/23/3/526

Documenti analoghi

Principles and Steps for Developing Human Resources in the LPQ Darul Muta'allimin Semarang
di: Zulfa Rahmasari, et al.
Pubblicazione: (2024-08-01)

Loss of LpqM proteins in Mycobacterium abscessus is associated with impaired intramacrophage survival
di: Yves-Marie Boudehen, et al.
Pubblicazione: (2024-05-01)

Mycobacterium tuberculosis extracellular vesicle-associated lipoprotein LpqH as a potential biomarker to distinguish paratuberculosis infection or vaccination from tuberculosis infection
di: Ainhoa Palacios, et al.
Pubblicazione: (2019-06-01)

Mycobacterium tuberculosis Rv0927c Inhibits NF-κB Pathway by Downregulating the Phosphorylation Level of IκBα and Enhances Mycobacterial Survival
di: Aihong Xia, et al.
Pubblicazione: (2021-08-01)

Computational prediction and experimental assessment of secreted/surface proteins from Mycobacterium tuberculosis H37Rv.
di: Carolina Vizcaíno, et al.
Pubblicazione: (2010-06-01)

Anti-Mycobacterial Peptides: From Human to Phage
di: Tieshan Teng, et al.
Pubblicazione: (2015-01-01)

Analysis of the noncoding RNA regulatory networks of H37Rv- and H37Rv△1759c-infected macrophages
di: Wenqi Dong, et al.
Pubblicazione: (2023-03-01)

Mendelian susceptibility to mycobacterial infection in man
di: J-L Casanova
Pubblicazione: (2001-08-01)

<it>Mycobacterium tuberculosis </it>Rv0679c protein sequences involved in host-cell infection: Potential TB vaccine candidate antigen
di: Vanegas Magnolia, et al.
Pubblicazione: (2010-04-01)

The efflux pumps Rv1877 and Rv0191 play differential roles in the protection of Mycobacterium tuberculosis against chemical stress
di: Carine Sao Emani, et al.
Pubblicazione: (2024-03-01)

Study on the RV Reducer based on Patent Map Technology
di: Chen Zhilan Chen Yunjie
Pubblicazione: (2019-12-01)

Transcription factors Rv0081 and Rv3334 connect the early and the enduring hypoxic response of Mycobacterium tuberculosis
di: Xian Sun, et al.
Pubblicazione: (2018-12-01)

In Silico Approach: Anti-Tuberculosis Activity of Caespitate in the H37Rv Strain
di: Andrea Moreno-Ceballos, et al.
Pubblicazione: (2024-06-01)

Truncation of C-Terminal Intrinsically Disordered Region of Mycobacterial Rv1915 Facilitates Production of “Difficult-to-Purify” Recombinant Drug Target
di: Monika Antil, et al.
Pubblicazione: (2020-05-01)

Research of Dynamic Characteristic of RV Reducer based on Bond Graph Theory
di: Liang Quan, et al.
Pubblicazione: (2020-06-01)

Study on Dynamics Simulation of RV Reducer based on Rigid-flexible Coupling
di: Qiu Tao Du Qungui
Pubblicazione: (2019-12-01)

Optimization Design of Part Tolerance of RV Reducer based on Genetic Algorithm
di: Xie Xiongwei, et al.
Pubblicazione: (2020-03-01)

Parametric Modeling of RV Reducer and Realization of 3D Printing Rapid Prototyping
di: Xiaxi Li, et al.
Pubblicazione: (2020-05-01)

Apical but not basal RV strain reflects right ventricular dysfunction in patients with dilated cardiomyopathy
di: Asmaa Ahmed Ali, et al.
Pubblicazione: (2023-05-01)

Multi-objective Optimization Design of RV Reducer Considering the Cycloid Gear Profile Modification
di: Wang Quan, et al.
Pubblicazione: (2020-04-01)

Design and Test Analysis of High Precision Test Bench of RV Reducer Transmission Error
di: Zhu Zhonggang, et al.
Pubblicazione: (2019-01-01)

Clinico-microbiological Profile of Nontuberculous Mycobacterial Keratitis
di: Richa Dhiman, et al.
Pubblicazione: (2022-05-01)

<i>Mycobacterium tuberculosis</i> Rv2387 Facilitates Mycobacterial Survival by Silencing TLR2/p38/JNK Signaling
di: Wu Li, et al.
Pubblicazione: (2022-08-01)

Mycobacterium tuberculosis Rv0309 Dampens the Inflammatory Response and Enhances Mycobacterial Survival
di: Yongchong Peng, et al.
Pubblicazione: (2022-02-01)

Phytocompounds as potential inhibitors of mycobacterial multidrug efflux pump Rv1258c: an in silico approach
di: Santasree Sarma Biswas, et al.
Pubblicazione: (2024-02-01)

A method for synthetic speech detection using local phase quantization
di: Jia XU, et al.
Pubblicazione: (2024-02-01)

A method for synthetic speech detection using local phase quantization
di: Jia XU, et al.
Pubblicazione: (2024-02-01)

Immunogenicity of RV1 and RV5 vaccines administered in standard and interchangeable mixed schedules: a randomized, double-blind, non-inferiority clinical trial in Mexican infants
di: Mercedes Macías-Parra, et al.
Pubblicazione: (2024-02-01)

Mycobacterium tuberculosis Rv1324 Protein Contributes to Mycobacterial Persistence and Causes Pathological Lung Injury in Mice by Inducing Ferroptosis
di: Xiaoxia Shi, et al.
Pubblicazione: (2023-02-01)

Mycobacterium tuberculosis Rv0790c inhibits the cellular autophagy at its early stage and facilitates mycobacterial survival
di: Jun Fang, et al.
Pubblicazione: (2022-11-01)

Personalized medicine approach in mycobacterial disease
di: Mehdi Mirsaeidi
Pubblicazione: (2012-01-01)

Towards personalized medicine in mycobacterial diseases; from bench to bedside
di: Mehdi Mirsaeidi
Pubblicazione: (2015-01-01)

The hydrolase LpqI primes mycobacterial peptidoglycan recycling
di: Patrick J. Moynihan, et al.
Pubblicazione: (2019-06-01)

The role of efflux pumps transporter in multi-drug resistant tuberculosis: Mycobacterial memberane protein(MmpL5)
di: Parissa Farnia, et al.
Pubblicazione: (2024-01-01)

Fitness costs of Mycobacterium tuberculosis resistant to rifampicin is compensated by rapid Th2 polarization mediated by early and high IL-4 production during mice infection
di: Ma. Fernanda Arce-Aceves, et al.
Pubblicazione: (2025-01-01)

Potential Mechanism of Action of meso-Dihydroguaiaretic Acid on Mycobacterium tuberculosis H37Rv
di: Aldo F. Clemente-Soto, et al.
Pubblicazione: (2014-12-01)

Lung Inflammation Resolution by RvD1 and RvD2 in a Receptor-Dependent Manner
di: Jin Gao, et al.
Pubblicazione: (2023-05-01)

Study of the Rv1417 and Rv2617c Membrane Proteins and Their Interactions with Nicotine Derivatives as Potential Inhibitors of Erp Virulence-Associated Factor in <i>Mycobacterium tuberculosis</i>: An In Silico Approach
di: Jorge Alberto Aguilar-Pineda, et al.
Pubblicazione: (2023-01-01)

Pulmonary Nontuberculous Mycobacterial Infection in Infants: A Systematic Review
di: Bai A, et al.
Pubblicazione: (2021-12-01)

Validating subcellular localization prediction tools with mycobacterial proteins
di: Niño Luis F, et al.
Pubblicazione: (2009-05-01)